Indeed, recent immune monitoring studies have shown that circulating cytotoxic granzyme B+, PD-1+ CD4+ T cells, as well as PD-1+ differentiated effector CD8+ T cells are detected in HL patients. Here, CD4 is linked to Hodgkins lymphoma.